Gao, A., Sun, T., Ma, G., Cao, J., Hu, Q., Chen, L., . . . Zhu, Z. (2018). LEM4 confers tamoxifen resistance to breast cancer cells by activating cyclin D-CDK4/6-Rb and ERα pathway. Nature Portfolio.
Cita Chicago Style (17a ed.)Gao, Ang, et al. LEM4 Confers Tamoxifen Resistance to Breast Cancer Cells by Activating Cyclin D-CDK4/6-Rb and ERα Pathway. Nature Portfolio, 2018.
Cita MLA (8a ed.)Gao, Ang, et al. LEM4 Confers Tamoxifen Resistance to Breast Cancer Cells by Activating Cyclin D-CDK4/6-Rb and ERα Pathway. Nature Portfolio, 2018.
Precaución: Estas citas no son 100% exactas.